logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

YIDU TECH (02158) spent approximately 1.9923 million Hong Kong dollars on repurchasing 400,000 shares on December 17th.

date
20:06 17/12/2025
avatar
GMT Eight
Yidu Technology (02158) announced that on December 17, 2025, it spent approximately HK$1.9923 million to repurchase 400,000 shares.
YIDU TECH (02158) announces on December 17, 2025 that it will allocate approximately HK$1.9923 million to repurchase 400,000 shares.
Related Articles
HK Stock
LIANLIAN (02598) spent HKD 996,500 on December 17 to repurchase 158,500 shares.
US Stock
Nebius (NBIS.US) launches the new generation AI cloud platform powered by NVIDIA Corporation's Blackwell Ultra chip to compete with CoreWeave.
HK Stock
BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.
LIANLIAN (02598) spent HKD 996,500 on December 17 to repurchase 158,500 shares.
HK Stock
Nebius (NBIS.US) launches the new generation AI cloud platform powered by NVIDIA Corporation's Blackwell Ultra chip to compete with CoreWeave.
US Stock
BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.
HK Stock
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
icon
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
icon
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
icon
16/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.